Groups examined

H, % M ± m

D, % M ± m

DH, % M ± m

DD, % M ± m

Patients with CAD, total, n = 10

64.3 ± 6.1^**

53.1 ± 10.2^**

15.6 ± 3.0^**

21.2 ± 6.1^**

Patients with CAD, subgroup 1, n = 6

65.1 ± 7.1^**

54.0 ± 5.8^**

19.3 ± 4.1^**

25.6 ± 6.8^**

Patients with CAD, subgroup 2, n = 4

63.5 ± 9.0^**

51.9 ± 7.9^**

14.0 ± 3.1^*

19.7 ± 5.0^**

Control group, n = 4

31.6 ± 6.1

9.4 ± 4.4

4.4 ± 1.2

2.8 ± 0.9